Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. - Wikidata - wikimedia - TriplyDB

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

http://www.wikidata.org/entity/Q34405383

about

Structure-Based Design of Novel Human Toll-like Receptor 8 Agonists Nanoparticles and direct immunosuppression Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-amines Synthesis and Evaluation of Conjugates of Novel TLR7 Inert Ligands as Self-Adjuvanting Immunopotentiators.Covalent modification of cell surfaces with TLR agonists improves & directs immune stimulation.Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity.Modulation of Innate Immune Responses via Covalently Linked TLR Agonists.HIV-1 gp140 epitope recognition is influenced by immunoglobulin DH gene segment sequence.Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants.Synthetic adjuvants for vaccine formulations: phytol derivatives.Applications of nanotechnology for immunology.The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.Directing the immune system with chemical compounds.Guiding principles in the design of molecular bioconjugates for vaccine applications.Strategies for designing synthetic immune agonists.Stimulation of innate immune cells by light-activated TLR7/8 agonists.Covalently coupled immunostimulant heterodimers.Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.Facile syntheses of functionalized toll-like receptor 7 agonists Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.Identification of Biologically Active Pyrimido[5,4-b]indoles That Prolong NF-κB Activation without Intrinsic Activity.New antagonists of toll-like receptor 7 discovered through 3D ligand-based virtual screening

P2860

Q27681499-42655507-0EEB-44F5-A711-13E916D8C5F8 Q28384480-4B9128A0-A535-4FAF-9770-BFEE8026981F Q30388683-1FDAC6B4-65DA-42C4-9978-1CB52A1809EB Q34164851-7B3874F4-2C25-42E9-B207-4CCA6726644F Q35178898-3E51743E-FD75-46D2-86C1-055ECF65BC42 Q35447388-C8B5BA2E-F78B-4F7A-A933-60CED4677E10 Q35826747-C85BADF4-ED6F-479E-94FE-912EF40A77A3 Q36147897-A9D4A284-BC1C-4C7E-8F63-7B9716D0BF6B Q36333881-13C20869-E12B-49A0-BB87-6EB8AF82DC8D Q36510483-43DA0F0F-5658-4AD9-ABE1-42FD582486AC Q37352073-BE5E6C31-DD2B-48B1-A2B1-790941120956 Q38072067-9FF136A8-1D89-452C-BBBC-9BB61F65D3EA Q38123937-9DCE12D7-D384-489D-8F36-6FB4DA743B3A Q38124064-A755852C-E92D-4B1A-89FF-9ABA68B52388 Q38201155-EC027605-806E-4810-9D2C-7D7265F89754 Q38395963-CE17DB10-6413-477F-9584-394DEE022D2F Q38841677-D5E052C1-C409-49D7-9A53-CC0014F37741 Q38974890-EEDBF178-CEF3-48C5-B5A2-29E3821DEF32 Q40459615-C0460C26-034E-4593-838B-52A99C630A29 Q42096062-EFDB4592-5B0D-43C3-B36C-F45CDCDE9814 Q42243654-2F9351E3-F87E-4071-B61A-47CCF433DE7C Q42385049-CEF1A77F-97D7-463D-8335-EDE4920A774D Q46360938-CE4EFB0E-A6F7-4C2C-B141-1B935449EC16 Q58215874-643F537F-C2FF-4823-A888-9F84B86F1BEF

P2860

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

http://www.wikidata.org/entity/Q34405383

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@ast

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@en

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@nl

type

label

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@ast

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@en

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@nl

prefLabel

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@ast

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@en

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@nl

P1433

Q34405383-06CED48F-5097-4B37-A84B-7CC3FBF8B4B7

P1476

Q34405383-E31DC176-E2E5-4DAE-A1DA-E7E84C3E8093

P2093

Q34405383-3F5F2932-4B00-4939-9496-AFEF0EC17AD2

Q34405383-695059EE-7E33-4B59-B992-4877C1DEB66F

Q34405383-8FCAF192-C7AB-4D14-B525-BD4B1C3743E5

Q34405383-A3D1247A-B6DE-4F8D-968D-399C636B47D9

Q34405383-D8A25A95-6A2F-4283-8223-13AF8AC2A132

Q34405383-E42DBEB7-2FED-4DE9-B3FF-3C1C7C18A0C8

P2860

Q34405383-058A2A0E-77D9-4B26-8E9B-590C10378A8D

Q34405383-0BA5CD2E-0DB9-4667-8324-5CC72C2CBDE3

Q34405383-188C6F67-202F-48DA-BBDF-3393E801A0BE

Q34405383-20A8B115-99C2-4A54-B755-08C8DEDB41B9

Q34405383-2956474A-263A-46B9-B604-0C45249DB37B

Q34405383-3D8C8BAB-FA9F-4296-AA09-4A3A918A72B0

Q34405383-44DBD658-1301-43A6-BF13-095F95AF6D5F

Q34405383-50C90827-E8A4-4AFD-93FC-3D565C1A77A1

Q34405383-5E00DEAB-E65F-4EE9-AE4C-E3E0E61407AC

Q34405383-677DE0F8-FA63-4EA7-BEFA-80D551C275B1

P304

Q34405383-3144E700-923C-46F9-ABC0-3C692BF20CA8

P31

Q34405383-2B4DBA45-6456-411A-BCBF-C5BE1ED02438

P356

Q34405383-E109DDDB-0318-45CC-9F18-77E5BF003BF2

P407

Q34405383-3834E5BA-82BA-46D0-A850-DF74330F1461

P433

Q34405383-F7667B47-CFC9-420C-B1CD-0B3CE4EF0ECE

P478

Q34405383-663C9F25-2706-4655-8C89-FE668F172F33

P577

Q34405383-AAFBA5D4-5F87-4ECC-9706-614490AF65BD

P5875

Q34405383-086F1F40-EE95-49F3-AA0E-B645EF8C2ECA

P698

Q34405383-C3BD4EE9-8A2A-49AC-ADB0-A75EE20DDFDC

P921

Q34405383-6060002C-2968-4E4E-8477-EEA11D669AC7

P932

Q34405383-D694309A-AC7E-47AC-9857-21AA9CDB34AE

P356

JOURNAL.PONE.0043612

P1433

P1476

Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer.

@en

P2093

Cole A Mutz

http://www.w3.org/2001/XMLSchema#string

Deepak B Salunke

http://www.w3.org/2001/XMLSchema#string

Nikunj M Shukla

http://www.w3.org/2001/XMLSchema#string

Rajalakshmi Balakrishna

http://www.w3.org/2001/XMLSchema#string

Subbalakshmi S Malladi

http://www.w3.org/2001/XMLSchema#string

Sunil A David

http://www.w3.org/2001/XMLSchema#string

P2860

The structural biology of Toll-like receptors

Prediction of the secondary structure of proteins from their amino acid sequence

Toll-like receptors as adjuvant receptors

Toll-like receptors: critical proteins linking innate and acquired immunity

New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites.

Antibody-protein interactions: benchmark datasets and prediction tools evaluation

Immunoprofiling toll-like receptor ligands: Comparison of immunostimulatory and proinflammatory profiles in ex vivo human blood models.

Toll-like receptors and innate immunity.

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Improved method for predicting linear B-cell epitopes.

P304

e43612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0043612

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230805273

http://www.w3.org/2001/XMLSchema#string

P698

22952720

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3429503

http://www.w3.org/2001/XMLSchema#string